ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will showcase its breakthrough molecular testing platform, the Encompass Optimum™ , at asm2015. The platform performs fully automated, complex molecular assays in an easy-to-use and economical format, addressing workflow and staffing obstacles that research laboratories are facing today. The 115th General Meeting of the American Society for Microbiology (ASM) will be held in New Orleans, May 30-June… Read More »
Rheonix®, Inc. has created a powerful microfluidic platform for the evolving molecular diagnostics industry that miniaturizes and automates all the functions of a molecular biology lab on a disposable chip the size of the palm of your hand. The Rheonix CARD® (Chemistry And Reagant Device) system incorporates disposable microfluidic chip technology and a scalable automated platform to analyze single or multiple clinical raw samples, providing multiplexed endpoint and/or real time analysis… Read More »
ITHACA, N.Y. — Rheonix, Inc., a developer of fully automated molecular testing solutions, has received a Small Business Innovation Research (SBIR) Phase II grant, under Award Number R44DE024456, from the National Institute of Dental & Craniofacial Research (NIDCR) of the National Institutes of Health (NIH). The grant will allow Rheonix to complete the development of a fully automated self-screening and confirming assay that can simultaneously detect HIV/AIDS antibodies and viral… Read More »
ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will participate in Festo Corp.’s workshop on “How Industrial Automation Solutions Improve Processes in the Lab” at the Society for Laboratory Automation and Screening’s (SLAS) fourth annual conference and exhibition. The press briefing for the workshop will be from 9:30 to 10:15 a.m., Feb. 10 at Booth 1123 at the Walter E. Washington Convention Center in Washington,… Read More »
ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will attend Piper Jaffray & Co.’s 20th Annual Health Care Conference on Dec. 2 at The New York Palace hotel. Tony Eisenhut, president of Rheonix, will participate in a panel on infectious disease along with John Bishop, chairman and CEO, Cepheid, and Randy Rasmussen, president, BioFire Diagnostics. The discussion will take place from 10 to 11 a.m.
The… Read More »
ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will attend the eighth annual International Strategy and Investment (ISI) Group’s MedTools and Outsourcing Investor Forum. The forum will take place Dec. 3-4 at the Boston Harbor Hotel, where leading companies from the life science tools, diagnostics and contract research organization (CRO) markets will have the opportunity to meet with key institutional investors.
“The MedTools and Outsourcing Investor… Read More »
It may not be Silicon Valley or New York City -- but Ithaca, N.Y., is working hard to position itself as a startup hub.
The city is home to three colleges, including Cornell University, which has heavily invested in fostering bright, entrepreneurial minds.
The university offers credits for students who want to take their startups to the next level, and introduced a new program to help students turn their technology designs into… Read More »
ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular diagnostics solutions, has been granted patent 8,852,919 “Microfluidic Apparatus, Method, and Applications” for its automated molecular system, the EncompassMDx™. This recent patent will help researchers and clinicians analyze tissue samples preserved in paraffin more efficiently, at a lower cost and with higher processing throughput.
The ‘919 patent automates a liquid-liquid extraction process that easily removes paraffin from preserved tissue samples… Read More »
ITHACA, N.Y. — Rheonix, Inc., a developer of fully automated molecular testing solutions, will be presenting at the inaugural BTIG Emerging Technologies in Healthcare Diagnostics symposium. Richard Montagna, Ph.D., senior vice president for Scientific and Clinical Affairs at Rheonix, will speak about genomic workflow innovation and discuss the company’s breakthrough innovation utilizing a proprietary liquid-liquid extraction methodology for automated preparation of paraffin-preserved tissue samples for nucleic acid analysis.
Dr. Montagna’s comments… Read More »
BUFFALO, N.Y.— The University at Buffalo’s New York State Center of Excellence in Bioinformatics & Life Sciences (CBLS) will host Rheonix, Inc., a molecular diagnostic company based in Ithaca, N.Y., to deliver September’s Life Sciences Commercialization Lecture.
The lecture will take place on Sept. 18 from 4 to 5 p.m. in the Bruce A. Holm Commons area (2nd floor), at the CBLS, 701 Ellicott Street, Buffalo.
Senior Vice President for Scientific and… Read More »